Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.
Journal: The New England journal of medicine
Published: April 08, 2026
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost.
Journal: Science translational medicine
Published: February 25, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.
Journal: Nature communications
Published: January 06, 2026
VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Regulation of CD45 isoforms during human effector and memory CD8 T cell differentiation: Implications for T cell nomenclature.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 05, 2025
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.
Journal: bioRxiv : the preprint server for biology
Published: July 17, 2025
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans.
Journal: Science (New York, N.Y.)
Published: May 15, 2025
Fixed dosing versus weight-based dosing of HIV-1 prophylactic monoclonal antibodies in adults: a post-hoc, cross-protocol pharmacokinetics modelling study.
Journal: EBioMedicine
Published: January 09, 2025
Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines.
Journal: Frontiers in immunology
Published: January 07, 2025
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
Journal: The Journal of infectious diseases
Published: December 31, 2024
Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIV.
Journal: BMC immunology
Published: October 22, 2024
Last Updated: 09/26/2026